Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 12, Issue 11, Pages 645-657
Publisher
Springer Nature
Online
2016-10-13
DOI
10.1038/nrrheum.2016.158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus
- (2016) Madhvi Menon et al. IMMUNITY
- Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells
- (2016) Andrew Getahun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma cells as an innovative target in autoimmune disease with renal manifestations
- (2016) Falk Hiepe et al. Nature Reviews Nephrology
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- (2015) Caroline von Spee-Mayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus
- (2015) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
- (2015) Alexis Mathian et al. DRUGS
- Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases
- (2015) Andreia C. Lino et al. IMMUNOLOGICAL REVIEWS
- Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus
- (2015) Natasha Jordan et al. Immunotherapy
- Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling
- (2015) Derek A. Holmes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Treatment of coexistent psoriasis and lupus erythematosus
- (2015) Sowmya Varada et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
- (2015) Eoin F. McKinney et al. NATURE
- HDAC inhibitors still need a home run, despite recent approval
- (2015) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy
- (2015) Karen M. Doody et al. Science Translational Medicine
- Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus
- (2015) Ji Hyun Sim et al. ARTHRITIS RESEARCH & THERAPY
- Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
- (2015) Adriano Taddeo et al. ARTHRITIS RESEARCH & THERAPY
- CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study
- (2015) Anthony Shock et al. ARTHRITIS RESEARCH & THERAPY
- Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
- (2015) Vanessa Fleischer et al. ARTHRITIS RESEARCH & THERAPY
- Manipulation of B-cell responses with histone deacetylase inhibitors
- (2015) Michaela Waibel et al. Nature Communications
- Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2015) Venkat Reddy et al. Arthritis & Rheumatology
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- The efficacy of novel B cell biologics as the future of SLE treatment: A review
- (2014) Ameer Kamal et al. AUTOIMMUNITY REVIEWS
- Safety of off-label biologicals in systemic lupus erythematosus
- (2014) Martin Aringer et al. Expert Opinion On Drug Safety
- Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
- (2014) William Stohl EXPERT OPINION ON THERAPEUTIC TARGETS
- MHC associations with clinical and autoantibody manifestations in European SLE
- (2014) D L Morris et al. GENES AND IMMUNITY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Antibodies to watch in 2015
- (2014) Janice M Reichert mAbs
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
- (2014) Julia Sieber et al. ARTHRITIS RESEARCH & THERAPY
- Increased Frequency of a Unique Spleen Tyrosine Kinase Bright Memory B Cell Population in Systemic Lupus Erythematosus
- (2014) Sarah J. Fleischer et al. Arthritis & Rheumatology
- Ustekinumab in the Treatment of Refractory Chronic Cutaneous Lupus Erythematosus: A Case Report
- (2013) C Dahl et al. ACTA DERMATO-VENEREOLOGICA
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis
- (2013) E. William St.Clair et al. ARTHRITIS AND RHEUMATISM
- Biologics in SLE: Towards new approaches
- (2013) Ronald F. van Vollenhoven et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- B cells
- (2013) Thomas Dörner et al. CURRENT OPINION IN RHEUMATOLOGY
- Exacerbated Autoimmunity in the Absence of TLR9 in MRL.Faslpr Mice Depends on Ifnar1
- (2013) K. M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Immunopathogenic mechanisms of systemic autoimmune disease
- (2013) Marie Wahren-Herlenius et al. LANCET
- Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
- (2013) B Duxbury et al. LUPUS
- Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms
- (2013) Chuanxin Huang et al. NATURE IMMUNOLOGY
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Taking a closer look at biologic therapy for SLE
- (2013) David A. Isenberg et al. Nature Reviews Rheumatology
- Emerging cell and cytokine targets in rheumatoid arthritis
- (2013) Gerd R. Burmester et al. Nature Reviews Rheumatology
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
- (2013) Daniel J. Wallace et al. RHEUMATOLOGY
- B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
- (2013) Venkat Reddy et al. ARTHRITIS RESEARCH & THERAPY
- Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
- (2012) Yuko Shirota et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
- (2012) N. Sieger et al. ARTHRITIS AND RHEUMATISM
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
- (2012) Chester V. Oddis et al. ARTHRITIS AND RHEUMATISM
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus
- (2012) D Winchester et al. LUPUS
- Protein tyrosine phosphatases in lymphocyte activation and autoimmunity
- (2012) Inmoo Rhee et al. NATURE IMMUNOLOGY
- From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
- (2012) Jacques Banchereau et al. NATURE IMMUNOLOGY
- B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels
- (2012) Mark N. Lazarus et al. RHEUMATOLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab
- (2011) Aieska De Souza ARCHIVES OF DERMATOLOGY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside
- (2011) William Stohl et al. CURRENT OPINION IN RHEUMATOLOGY
- An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus
- (2011) A. Ahuja et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice
- (2011) P. Scapini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T cell lineage commitment in the thymus
- (2011) Ludger Klein et al. SEMINARS IN IMMUNOLOGY
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
- (2011) Hans-Peter Tony et al. ARTHRITIS RESEARCH & THERAPY
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
- (2010) S. IWATA et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
- (2010) Capucine Daridon et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity
- (2009) Vicky Lampropoulou et al. IMMUNOLOGICAL REVIEWS
- A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus
- (2009) Vesela Gateva et al. NATURE GENETICS
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- Class-switched B cells display response to therapeutic B cell depletion in rheumatoid arthritis
- (2009) Burkhard Moller et al. ARTHRITIS RESEARCH & THERAPY
- Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
- (2009) Maria Rehnberg et al. ARTHRITIS RESEARCH & THERAPY
- B cells in autoimmunity
- (2009) Thomas Dörner et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
- (2009) Magda Nakou et al. ARTHRITIS RESEARCH & THERAPY
- Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment
- (2008) Petra Roll et al. ARTHRITIS AND RHEUMATISM
- Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis
- (2008) Gregg J. Silverman et al. IMMUNOLOGICAL REVIEWS
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Association of Systemic Lupus Erythematosus withC8orf13–BLKandITGAM–ITGAX
- (2008) Geoffrey Hom et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started